Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 18369923)

Published in Methods Mol Biol on January 01, 2008

Authors

Geoffrey M Thiele1, Lynell W Klassen, Dean J Tuma

Author Affiliations

1: Department of Veterans Affairs Medical Center, University of Nebraska Medical Center, Omaha, OH, USA.

Articles citing this

Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev (2014) 2.66

Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev (2010) 1.18

Focus on: Alcohol and the immune system. Alcohol Res Health (2010) 1.11

Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model. Alcohol Clin Exp Res (2010) 1.01

Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic Biol Med (2010) 0.92

Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med (2012) 0.91

Modeling human liver biology using stem cell-derived hepatocytes. Int J Mol Sci (2013) 0.80

Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome. J Biol Chem (2013) 0.79

Update on Alcoholic Hepatitis. Biomolecules (2015) 0.78

Is there a role for adaptive immunity in nonalcoholic steatohepatitis? World J Hepatol (2015) 0.76

Alcohol and Viral Hepatitis: Role of Lipid Rafts. Alcohol Res (2015) 0.75

Biomarkers of alcohol misuse: recent advances and future prospects. Prz Gastroenterol (2016) 0.75

Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies. Exp Mol Pathol (2017) 0.75

Articles by these authors

High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. Ann Thorac Surg (2011) 2.25

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis. Arthritis Rheumatol (2015) 1.58

Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol (2006) 1.39

A comparison of the effects of betaine and S-adenosylmethionine on ethanol-induced changes in methionine metabolism and steatosis in rat hepatocytes. J Nutr (2005) 1.20

Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology (2002) 1.19

Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol (2003) 1.18

Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cells. J Hepatol (2005) 1.15

Betaine administration corrects ethanol-induced defective VLDL secretion. Mol Cell Biochem (2009) 1.12

Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis (2004) 1.07

Relaxin receptors in hepatic stellate cells and cirrhotic liver. Biochem Pharmacol (2006) 1.06

Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J Nutr (2003) 1.06

Chronic ethanol consumption induces global hepatic protein hyperacetylation. Alcohol Clin Exp Res (2009) 1.05

Role of elevated S-adenosylhomocysteine in rat hepatocyte apoptosis: protection by betaine. Biochem Pharmacol (2005) 1.05

WIF-B cells as a model for alcohol-induced hepatocyte injury. Biochem Pharmacol (2004) 1.05

IL-6 and its receptors in coronary artery disease and acute myocardial infarction. Cytokine (2013) 1.05

Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcohol Clin Exp Res (2011) 1.05

Ethanol-induced oxidative stress suppresses generation of peptides for antigen presentation by hepatoma cells. Hepatology (2007) 1.04

Methionine synthase. a possible prime site of the ethanolic lesion in liver. Alcohol (2002) 1.02

Microtubule acetylation and stability may explain alcohol-induced alterations in hepatic protein trafficking. Hepatology (2008) 1.02

Ethanol-induced apoptosis in polarized hepatic cells possibly through regulation of the Fas pathway. Alcohol Clin Exp Res (2006) 1.01

Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. Alcohol Clin Exp Res (2004) 1.00

Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease. World J Gastroenterol (2009) 0.98

The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology (2002) 0.97

Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury. Alcohol (2011) 0.97

Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol (2005) 0.97

Malondialdehyde-acetaldehyde adducts decrease bronchial epithelial wound repair. Alcohol (2005) 0.95

Alcohol-induced alterations in hepatic microtubule dynamics can be explained by impaired histone deacetylase 6 function. Hepatology (2008) 0.95

Multilevel regulation of autophagosome content by ethanol oxidation in HepG2 cells. Autophagy (2012) 0.94

Accumulation of proteins bearing atypical isoaspartyl residues in livers of alcohol-fed rats is prevented by betaine administration: effects on protein-L-isoaspartyl methyltransferase activity. J Hepatol (2007) 0.94

Betaine treatment attenuates chronic ethanol-induced hepatic steatosis and alterations to the mitochondrial respiratory chain proteome. Int J Hepatol (2011) 0.93

Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res (2002) 0.93

Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic Biol Med (2010) 0.92

Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcohol Clin Exp Res (2007) 0.92

Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells. Hepatology (2003) 0.92

Effect of ethanol on pro-apoptotic mechanisms in polarized hepatic cells. World J Gastroenterol (2007) 0.90

Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells. Comp Hepatol (2004) 0.90

An in vitro method of alcoholic liver injury using precision-cut liver slices from rats. Biochem Pharmacol (2008) 0.89

Transforming growth factor-beta induces contraction of activated hepatic stellate cells. J Hepatol (2004) 0.88

Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. Int Immunopharmacol (2012) 0.88

Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res (2010) 0.88

Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol. Biochem Pharmacol (2005) 0.88

T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int Immunopharmacol (2003) 0.87

Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res (2005) 0.87

Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells. World J Gastroenterol (2009) 0.87

Organic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss/disease. Am J Respir Cell Mol Biol (2013) 0.87

Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochem Biophys Res Commun (2009) 0.87

Effect of malondialdehyde-acetaldehyde-protein adducts on the protein kinase C-dependent secretion of urokinase-type plasminogen activator in hepatic stellate cells. Biochem Pharmacol (2002) 0.86

Malondialdehyde-acetaldehyde haptenated protein binds macrophage scavenger receptor(s) and induces lysosomal damage. Int Immunopharmacol (2004) 0.84

Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 0.84

Chronic ethanol treatment impairs Rac and Cdc42 activation in rat hepatocytes. Alcohol Clin Exp Res (2006) 0.84

Ethanol selectively impairs clathrin-mediated internalization in polarized hepatic cells. Biochem Pharmacol (2009) 0.83

Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci (2004) 0.82

RSA 2004: combined basic research satellite symposium-mechanisms of alcohol-mediated organ and tissue damage: inflammation and immunity and alcohol and mitochondrial metabolism: at the crossroads of life and death session one: alcohol, cellular and organ damage. Alcohol Clin Exp Res (2005) 0.82

Aldehydes in cigarette smoke react with the lipid peroxidation product malonaldehyde to form fluorescent protein adducts on lysines. Chem Res Toxicol (2005) 0.82

Lipid droplet accumulation and impaired fat efflux in polarized hepatic cells: consequences of ethanol metabolism. Int J Hepatol (2012) 0.81

Rab GTPases associate with isolated lipid droplets (LDs) and show altered content after ethanol administration: potential role in alcohol-impaired LD metabolism. Alcohol Clin Exp Res (2013) 0.81

Lysine acetylation induced by chronic ethanol consumption impairs dynamin-mediated clathrin-coated vesicle release. Hepatology (2012) 0.80

Chronic ethanol consumption impairs receptor-mediated endocytosis of MAA-modified albumin by liver endothelial cells. Biochem Pharmacol (2003) 0.80

Relaxin decreases the severity of established hepatic fibrosis in mice. Liver Int (2013) 0.80

Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis. Am J Physiol Gastrointest Liver Physiol (2013) 0.79

Vitamin D supplementation protects against bone loss following inhalant organic dust and lipopolysaccharide exposures in mice. Immunol Res (2015) 0.79

Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis. Ann N Y Acad Sci (2009) 0.79

Polyclonal antibody to soman-tyrosine. Chem Res Toxicol (2013) 0.79

Hepatic microtubule acetylation and stability induced by chronic alcohol exposure impair nuclear translocation of STAT3 and STAT5B, but not Smad2/3. Am J Physiol Gastrointest Liver Physiol (2012) 0.78

Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury. J Biol Chem (2010) 0.78

Immunological response in alcoholic liver disease. World J Gastroenterol (2007) 0.78

Susceptibility to T cell-mediated liver injury is enhanced in asialoglycoprotein receptor-deficient mice. Int Immunopharmacol (2013) 0.78

Alcohol, carcinoembryonic antigen processing and colorectal liver metastases. Adv Exp Med Biol (2015) 0.78

Inhibition of hepatic stellate cell collagen synthesis by N-(methylamino)isobutyric acid. Biochem Pharmacol (2002) 0.77

Malondialdehyde-acetaldehyde-haptenated protein induces cell death by induction of necrosis and apoptosis in immune cells. Int Immunopharmacol (2002) 0.77

ATA2-mediated amino acid uptake following partial hepatectomy is regulated by redistribution to the plasma membrane. Arch Biochem Biophys (2002) 0.77

Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde. Int Immunopharmacol (2008) 0.77

Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant. Immunol Res (2014) 0.77

Alcohol consumption decreases rat hepatic creatine biosynthesis via altered guanidinoacetate methyltransferase activity. Alcohol Clin Exp Res (2013) 0.77

Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue. Ann N Y Acad Sci (2005) 0.77

Cyanamide potentiates the ethanol-induced impairment of receptor-mediated endocytosis in a recombinant hepatic cell line expressing alcohol dehydrogenase activity. Int J Hepatol (2012) 0.76

In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability. Alcohol Clin Exp Res (2002) 0.76

Alcohol-induced defects in hepatic transcytosis may be explained by impaired dynein function. Mol Cell Biochem (2014) 0.75

Halothane potentiates the alcohol-adduct induced TNF-alpha release in heart endothelial cells. BMC Anesthesiol (2005) 0.75

A method for the making and utility of gadolinium-labeled albumin microbubbles. Magn Reson Imaging (2011) 0.75

Ultrasound imaging in an animal model of vascular inflammation following balloon injury. Ultrasound Med Biol (2012) 0.75